Imperva Announces Fourth Quarter and Full Year 2016 Financial Results

Go back to Imperva Announces Fourth Quarter and Full Year 2016 Financial Results

Oppenheimer Reiterates Outperform Rating on Imperva (IMPV) Following Strong Q4

February 9, 2017 6:24 AM EST

Oppenheimer analyst Shaul Eyal reiterates Outperform rating and $55 price target on Imperva Inc. (NYSE: IMPV), as the company reported strong 2016 fourth quarter results, beating most consensus estimates across the board, while divesting of Skyfence assets.

Eyal comments, "IMPV reported strong 4Q16 results, beating... More